feed,title,long_url,short_url
Benzinga,"Analyst Outlines Doubts On This NASH-Focused Stock, Builds Neutral Case",https://benzinga.com/general/biotech/22/09/28834690/with-some-doubts-hc-wainwright-initiates-coverage-on-this-nash-focused-stock,https://bit.ly/3U3ZukF
Benzinga,"This Cancer Focused Stock Has 60% Potential Upside, Bullish Analyst Says",https://benzinga.com/general/biotech/22/09/28834629/hc-wainwright-initiates-coverage-on-this-cancer-stock-with-60-upside,https://bit.ly/3QyGWWR
